InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Inks Acquisition Agreement with Perfect Day for Its Urgent Company, Consumer Brands Portfolio

TRxADE Health (NASDAQ: MEDS), a pharmaceutical exchange platform provider that recently merged with food technology and distribution company Superlatus Inc., announced an acquisition agreement. The company has entered a binding agreement with Perfect Day Inc. to acquire the Urgent Company Inc. along with its Coolhaus, Brave Robot, Modern Kitchen and California Performance Co. consumer brands. According to the announcement, the combined company will have a sustained, equitable food portfolio designed to penetrate new markets and accelerate a transition to animal-free brands more readilySuperlatus is a diversified food-technology company with distribution capabilities that is working to scale food innovation and transformational change designed to optimize food security and population health via innovative CPG products, agritech, foodtech, plant-based proteins and alt-proteins.

A new type of CPG company, the Urgent Company is focused on the next generation of consumer brands that leverage the latest in innovation and science to create revolutionary, delicious and sustainable animal-free foods that create less impact on the planet. “We are excited to welcome the Coolhaus, Brave Robot, Modern Kitchen and California Performance Co. brands to our portfolio of CPG assets,” said Superlatus interim CEO Tim Alford in the press release. “Together, our shared interest in the sustainable and equitable food sectors will, we believe, allow us to expand our market presence and pursue a number of new opportunities to grow our brands together. In addition, once complete, this acquisition will help accelerate both companies’ environmental mission to transition our products to animal free in the months and years ahead.”

To view the full press release, visit

About TRxADE Health Inc.

TRxADE is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug-procurement marketplace serving more than 14,500 members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient centric telehealth services. For more information about the company, please visit

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.